tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CRSP Stock Latest News

Crispr Therapeutics price target raised to $33 from $32 at Morgan Stanley
The FlyCrispr Therapeutics price target raised to $33 from $32 at Morgan Stanley
1d ago
CRSP
VRTX
IHI, IHE, ARKG: Specialty Healthcare ETFs Can Help Boost a Portfolio
PremiumMarket News
IHI, IHE, ARKG: Specialty Healthcare ETFs Can Help Boost a Portfolio
2d ago
BSX
IHE
Crispr Therapeutics price target lowered to $67 from $69 at JPMorgan
PremiumThe Fly
Crispr Therapeutics price target lowered to $67 from $69 at JPMorgan
2d ago
CRSP
Crispr Therapeutics price target raised to $80 from $77 at Citi
PremiumThe Fly
Crispr Therapeutics price target raised to $80 from $77 at Citi
2d ago
CRSP
CRISPR Therapeutics: Casgevy Outperformance and 2026 Pipeline Catalysts Drive Raised $80 Target and Buy, High Risk Rating
PremiumRatings
CRISPR Therapeutics: Casgevy Outperformance and 2026 Pipeline Catalysts Drive Raised $80 Target and Buy, High Risk Rating
2d ago
CRSP
Crispr Therapeutics price target raised to $76 from $74 at Chardan
PremiumThe FlyCrispr Therapeutics price target raised to $76 from $74 at Chardan
4d ago
CRSP
Crispr Therapeutics price target raised to $74 from $62 at Evercore ISI
Premium
The Fly
Crispr Therapeutics price target raised to $74 from $62 at Evercore ISI
5d ago
CRSP
VRTX
Crispr Therapeutics price target raised to $82 from $80 at Needham
Premium
The Fly
Crispr Therapeutics price target raised to $82 from $80 at Needham
5d ago
CRSP
Crispr Therapeutics price target raised to $45 from $40 at TD Cowen
PremiumThe Fly
Crispr Therapeutics price target raised to $45 from $40 at TD Cowen
5d ago
CRSP
CRISPR Therapeutics: Casgevy Outperformance and Advancing In Vivo Pipeline Underpin Buy Rating
PremiumRatings
CRISPR Therapeutics: Casgevy Outperformance and Advancing In Vivo Pipeline Underpin Buy Rating
5d ago
CRSP
Crispr Therapeutics price target lowered to $86 from $89 at BofA
PremiumThe Fly
Crispr Therapeutics price target lowered to $86 from $89 at BofA
5d ago
CRSP
CRISPR Therapeutics: Buy-Rated, Multi-Franchise Gene-Editing Platform with Strengthening CASGEVY Launch and Catalyst-Rich 2026 Outlook
PremiumRatings
CRISPR Therapeutics: Buy-Rated, Multi-Franchise Gene-Editing Platform with Strengthening CASGEVY Launch and Catalyst-Rich 2026 Outlook
5d ago
CRSP
Maintaining a Hold: Casgevy Outperformance Balanced by Pipeline Execution Risks and Limited Valuation Upside
PremiumRatingsMaintaining a Hold: Casgevy Outperformance Balanced by Pipeline Execution Risks and Limited Valuation Upside
6d ago
CRSP
Crispr Therapeutics: Buy Rating on Strengthening Casgevy Trajectory and High-Value In Vivo Gene-Editing Pipeline
Premium
Ratings
Crispr Therapeutics: Buy Rating on Strengthening Casgevy Trajectory and High-Value In Vivo Gene-Editing Pipeline
6d ago
CRSP
Crispr Therapeutics reports Q4 EPS ($1.37), consensus ($1.23)
Premium
The Fly
Crispr Therapeutics reports Q4 EPS ($1.37), consensus ($1.23)
6d ago
CRSP
IBM, P&G, GameStop, Crispr, AGNC: Insider Moves Exposed
PremiumWeekend Updates
IBM, P&G, GameStop, Crispr, AGNC: Insider Moves Exposed
18d ago
PG
GME
Crispr Therapeutics price target lowered to $80 from $86 at Citizens
PremiumThe Fly
Crispr Therapeutics price target lowered to $80 from $86 at Citizens
19d ago
CRSP
Cathie Wood Buys the Dip in Joby Aviation (JOBY), Sells Teradyne (TER) Near Highs
PremiumMarket News
Cathie Wood Buys the Dip in Joby Aviation (JOBY), Sells Teradyne (TER) Near Highs
19d ago
TER
ARKQ
Cathie Wood’s ARK Investment buys 127K shares of Crispr Therapeutics today
PremiumThe Fly
Cathie Wood’s ARK Investment buys 127K shares of Crispr Therapeutics today
20d ago
CRSP
Cathie Wood’s ARK Investment buys 120K shares of Crispr Therapeutics today
PremiumThe FlyCathie Wood’s ARK Investment buys 120K shares of Crispr Therapeutics today
21d ago
CRSP
Crispr Therapeutics price target lowered to $89 from $90 at BofA
Premium
The Fly
Crispr Therapeutics price target lowered to $89 from $90 at BofA
27d ago
CRSP
CRISPR Therapeutics Highlights Pipeline Advances in Gene-Edited Therapies
Premium
Company Announcements
CRISPR Therapeutics Highlights Pipeline Advances in Gene-Edited Therapies
1M ago
8K
CRSP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >